SEC Form 4 · accession 0001209191-15-068028
Neurogene Inc. · NGNE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David Chilton Mitchell
Officer — VP Global Regulatory & Quality
Period of report
Aug 24, 2015
Accepted (ET)
Aug 26, 2015 · 4:48 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001404644
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 24, 2015 | P | 3,575 | $17.81 | A | 3,575 | I | By spouse |
| Common Stock | holding | — | — | — | 1,600 | D |
Table II — derivative securities
No Table II lines on this filing.